The absence of S100a9 in the stroma did not have an effect on the development of fibrosis in the TPO‐induced MPN/fibrosis model, and megakaryocyte abnormalities were comparable in S100a9 and WT recipients (Figure S3B). This evidence concerns the gene S100A9 and myeloproliferative disorder.